Novo Nordisk is now offering its anti-obesity drug for as low as $199 per month

Novo Nordisk (NYSE: NVO) has announced sweeping price cuts for its blockbuster GLP-1 drugs, Wegovy and Ozempic, offering patients access to the lowest doses for just $199/month. New cash-paying patien... ...